Next Article in Journal
Serine Metabolism in Health and Disease and as a Conditionally Essential Amino Acid
Previous Article in Journal
Association of the Dietary Inflammatory Index with Depressive Symptoms among Pre- and Post-Menopausal Women: Findings from the National Health and Nutrition Examination Survey (NHANES) 2005–2010
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Nutrients
Volume 14
Issue 9
10.3390/nu14091986
nutrients-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Alterations in Bacterial Metabolism Contribute to the Lifespan Extension Exerted by Guarana in Caenorhabditis elegans

by
Inés Reigada
1,*,
Karmen Kapp
1,
Claire Maynard
2,
David Weinkove
2,
Marta Sofía Valero
3,4,
Elisa Langa
5,
Leena Hanski
1 and
Carlota Gómez-Rincón
4,5
1
Drug Research Program, Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, 00014 Helsinki, Finland
2
Department of Biosciences, Durham University, Durham DH1 3LE, UK
3
Department of Pharmacology, Physiology and Legal and Forensic Medicine, University of Zaragoza, 50009 Huesca, Spain
4
Instituto Agroalimentario de Aragón-IA2 (CITA-Universidad de Zaragoza), 50013 Zaragoza, Spain
5
Department of Pharmacy, Faculty of Health Science, Universidad San Jorge (San Jorge University), 50830 Zaragoza, Spain
*
Author to whom correspondence should be addressed.
Nutrients 2022, 14(9), 1986; https://doi.org/10.3390/nu14091986
Submission received: 31 March 2022 / Revised: 3 May 2022 / Accepted: 5 May 2022 / Published: 9 May 2022
(This article belongs to the Section Nutrition and Public Health)
Browse Figures
Review Reports Versions Notes

Abstract

:
Guarana (Paullinia cupana) is a widely consumed nutraceutical with various health benefits supported by scientific evidence. However, its indirect health impacts through the gut microbiota have not been studied. Caenorhabditis elegans is a useful model to study both the direct and indirect effects of nutraceuticals, as the intimate association of the worm with the metabolites produced by Escherichia coli is a prototypic simplified model of our gut microbiota. We prepared an ethanoic extract of guarana seeds and assessed its antioxidant capacity in vitro, with a 2,2-diphenyl-1-picrylhydrazyl (DPPH) assay, and in vivo, utilizing C. elegans. Additionally, we studied the impact of this extract on C. elegans lifespan, utilizing both viable and non-viable E. coli, and assessed the impact of guarana on E. coli folate production. The extract showed high antioxidant capacity, and it extended worm lifespan. However, the antioxidant and life-extending effects did not correlate in terms of the extract concentration. The extract-induced life extension was also less significant when utilizing dead E. coli, which may indicate that the effects of guarana on the worms work partly through modifications on E. coli metabolism. Following this observation, guarana was found to decrease E. coli folate production, revealing one possible route for its beneficial effects.

Graphical Abstract

1. Introduction

In the last few decades, the consumption of dietary supplements and nutraceuticals has dramatically increased [1]. The popularity of many nutraceuticals is based on the health benefits granted to them by traditional use, guarana (Paullinia cupana, Sapindaceae) being an excellent example. The seeds of this evergreen climbing shrub have been consumed for centuries by the native Brazilian population [2], who used the seeds as a stimulant to hunt, as a potent diuretic and also to reduce fever and headaches [2]. Currently, guarana is sold as a dietary supplement in the form of tablets and capsules, but it is also often found as part of energy drinks, given the increasing preference of consumers for natural products [3].
The pharmaceutical properties of guarana have been extensively studied by the research community, and many of the obtained results provide evidence for its antioxidant [4], anti-inflammatory [5], neuroprotective [6], anti-fatigue [7], hypocholesterolemic [8], and anti-obesity effects [9,10]. However, as with many other oral supplements, the impact of guarana on bacterial metabolism and, therefore, its potential impact on the microbiota, has been less explored.
Diet and dietary supplements can directly or indirectly affect the human body. The direct effects involve those caused by the absorbance of nutrients and compounds from the diet itself, while the indirect dietary effects are those mediated by the microbial community in the digestive track [11]. The enormous impact that the microbiota composition and stability have on human health is currently well known, and the role of diet in significantly affecting the functionality of the microbiota is generally acknowledged [12]. For instance, it has been observed that the gut microbiota of the elder population and patients with inflammatory bowel diseases (IBD) are characterized by an overgrowth of proteobacteria and increased serum folate levels [13,14]. These bacteria are able to synthesize folate de novo, which has been hypothesized to increase folate-dependent toxicity, which may damage tissues, promote inflammation and accelerate aging [12]. Thus, it would be relevant to evaluate the impact of nutraceuticals and dietary supplements on bacterial metabolism, for instance, assessing their impact on proteobacteria folate production [15,16].
Caenorhabditis elegans has proven to be a very useful model organism to scientifically assess the properties and safety of nutraceuticals, as it manages to shorten the translational gap between the in vitro and the in vivo conditions, avoiding the ethical concerns of other animal models. Besides, their relatively short lifespan, the easy propagation of populations of synchronized individuals, and their genetics, make C. elegans a powerful model for the study of aging and health-promoting effects of exogenous substances [17,18].
In fact, C. elegans has been previously used to shed some light on the mechanism of action insights behind the antioxidant, anti-aging, and neuroprotective capacity of guarana [19,20,21]. Moreover, C. elegans has proven to be a supreme tool for the study of microbe–host relations, being a suitable model for the assessment of the molecular processes involved in pathogenic and commensal interactions [22]. The usefulness of this model lies in the fact that these molecular processes are often conserved in other organisms of interest, such as humans [22]. For instance, at the intestinal level, there are morphological similarities in the intestinal cellular structure between C. elegans and humans, enabling comparison of extraction functionalities and absorption of nutrients [22]. Besides, bacteria can also colonize the intestine of C. elegans and this association may benefit the host, as it happens with the human microbiota [23]. In laboratory conditions, C. elegans are often exposed exclusively to the Gram-negative bacterium, Escherichia coli. During development and in young adult worms, the interaction is primarily nutritional, E.coli acting as the main nutrient of the worm [16]. However, upon aging, E. coli colonize the intestine of the worm, shifting the host–microbe relationship. While E. coli does not constitute standard microbiota, the intimate association of the worm with the metabolites produced by this bacterium throughout its lifespan provides a relevant model to study the impact on the variations of the bacterial metabolism on the health of the host [16]. For instance, it has been previously observed that the inhibition of E. coli folate production slows C. elegans aging [24,25]. This could make C. elegans an interesting model to identify potentially beneficial nutraceuticals in pathological processes, characterized by microbiota dysbiosis and increased bacterial folate production.
Therefore, in this study, we utilized the in vivo model, C. elegans, to characterize the properties of guarana, not only by assessing its direct effects on the worm, but also through its impact on E. coli metabolism. To do so, we chemically characterized an ethanolic extract of guarana seeds and we assessed its antioxidant capacity in vitro and in C. elegans. Additionally, we assessed the impact of this extract on the worm lifespan and to assess if the extract effects were given directly to the worm, or throughout its impact on the bacterial metabolism, and we utilized both viable and non-viable E. coli. Finally, we assessed the impact of guarana on E. coli folate production.

2. Materials and Methods

2.1. Plant Material and Extraction

Dry guarana seeds were provided by Plantarom® (Montreal, QC, Canada) and stored at room temperature protected from humidity and direct light until use. The seeds were crushed to homogeneous particle size. The crushed guarana seeds (50 g in total) were introduced to a Soxhlet apparatus and the extraction was performed with ethanol (96%) for 4 h [26]. The extract was evaporated to dryness with a rotary flash evaporator (Büchi® Rotavapor® R-210, Büchi laboratories, Flawil, Switzerland) and the extract was preserved at −20 °C until further use.

2.2. UPLC-PDA-MS Analyses

Guarana seed extract was dissolved in 50% aqueous ethanol for the stock solution of 5.0 mg/mL. The extract was vortexed, sonificated at RT for 15 min and filtered through 0.45 µm polypropylene syringe filter (VWR, Radnor, PA, USA). For the UPLC-MS analyses, a working solution with a concentration of 100 µg/mL was prepared. Identification of compounds was achieved using analytical reversed-phase UPLC-MS system.
The chromatographic system consisted of Acquity UPLC (Waters, Milford, MA, USA) equipped with a photo-diode array (PDA) detector (Waters, Milford, MA, USA) coupled to a mass single-quadrupole detector (QDa, Waters) with an electrospray ionization (ESI) interface. Empower software v. 3.0 was used for instrument control and data acquisition. Samples were separated on an Ascentis® Express HPLC column (50 mm × 2.1 mm, 2.0 μm, Supelco, Beliefonte, PA, USA). Column temperature and sample injection volume were, respectively, set to be 30 °C and 2.0 μL.
With the PDA detector, the mobile phase comprised a mixture of 15 mM KH2PO4 pH 2.0 (solvent A, Sigma-Aldrich, St. Louis, MO, USA) and acetonitrile (solvent B, ChromasolvTM, Honeywell Research Chemicals, Morris Plains, NJ, USA). A 10-min gradient program was used, beginning with 10% B, increasing to 80% at 8 min and a decrease to 10% B, holding for 2 min. The flow rate of the mobile phase was 0.5 mL/min. Compounds were monitored with Max plot chromatogram.
For the UPLC-MS runs, the mobile phase comprised a mixture of acetonitrile (solvent A, ChromasolvTM, Honeywell Research Chemicals, Morris Plains, NJ, USA) and 0.1% v/v formic acid (solvent B, Merck, Darmstadt, Germany) in water. An 8-min gradient program was used, beginning with 5% B, increasing to 70% at 7 min and a decrease to 5% B, holding for 1 min. The flow rate of the mobile phase was 0.5 mL/min. The QDa conditions were set as follows: a cone voltage of 45 V, a capillary voltage of 0.8 kV, and a source temperature of 600 °C. Runs were performed with ESI interface working in negative ionization and positive ionization, acquired in the range of 150–800 Da.

2.3. Strains and Culture Conditions

The C. elegans strains, N2 (wild type) and SS104 glp-4(bn2) used in this study were obtained from Caenorhabditis Genetics Center (CGC), Minneapolis, MN, USA. The SS104 glp-4(bn2) strain was used as the inserted mutation causes the worms not to produce offspring at a temperature of 25 °C, which facilitates the counting and handling of lifespan assays.
Both strains were maintained in Nematode Growth Media (NGM) agar plates seeded with a lawn of Escherichia coli OP50 (CGC, Minneapolis, MN, USA). Miller’s lysogeny broth and agar (LB; Fisher BioReagents, Pittsburg, PA, USA) were used for maintenance and growth of E. coli. To generate the bacterial lawn on NGM, 80 µL of a pre-culture of E. coli (10 μL of a glycerol stock in 5 mL of LB incubated for 18 h at 37 °C, 120 rpm) was seeded on the agar plates and incubated overnight at 37 °C. NGM medium was prepared as described [27], using 0.003 g/mL NaCl; 0.0025 g/mL peptone; 0.017 g/mL high-purity agar; 0.1% Cholesterol; 0.1% MgSO4 (1M); 0.1% CaCl2 (1M), and 2.5% of Potassium Buffer (1M) (all purchased from Sigma-Aldrich, St. Louis, MO, USA). The wild-type strain was routinely maintained at 20 °C while SS104 was maintained at 15 °C.

2.4. Antioxidant Activity In Vitro: DPPH Method

The free radical activity of the extract was evaluated by the 2, 2-diphenyl-1-picrylhydrazyl (DPPH; Sigma-Aldrich, St. Louis, MO, USA) method following the protocol of López, et al. [28]. The extract was serially diluted in ethanol (concentrations ranging from 1 to 500 µg/mL) and 150 µL of each dilution was mixed with 150 μL of a DPPH ethanolic solution (0.04 mg/mL). Epicatechin and the positive control, ascorbic acid (Sigma-Aldrich, St. Louis, MO, USA), were used at concentrations ranging from 1 to 100 µg/mL. After 30 min of incubation (room temperature, in the darkness) the absorbance was measured at 517 nm [29]. The control samples consisted of all the reagents excluding the plant extract. The background interferences from solvents were deducted from the activity values of the corresponding extracts prior to calculating the percentage of Radical Scavenging Capacity (%RSC) as follows: % RSC = ((Abscontrol − Abssample)/Abscontrol) × 100, where Abscontrol is the absorbance of the control and Abssample is the absorbance of the sample.
The 50% effective concentration (EC50), in this case, the concentration effective in producing 50% of the maximal RSC, was calculated for the guarana extract and the positive control, ascorbic acid.

2.5. Stress-Resistance Assays

For the stress-resistance assays, the protocol of Reigada, et al. [30] was followed. Briefly, eggs were prepared by bleaching adults and incubated in M9 buffer (6 g/L Na2HPO4; 3/L g KH2PO4; 5 g/L NaCl; 0.25 g/L MgSO4 × 7H2O in MQ water; all reagents from Sigma-Aldrich, St. Louis, MO, USA) until the hatching of the eggs (L1 stage). L1 larvae were incubated in NGM containing E. coli OP50 and different concentrations of guarana (100, 250 and 500 µg/mL) until L4 stage. Non-supplemented NGM plates were used as controls. After the incubation period the adults were transferred to fresh NGM plates containing 150 µM juglone (5-hydroxy-1,4-naphthalenedione; Sigma-Aldrich, St. Louis, MO, USA). Resistance to oxidative stress was assessed by counting the alive worms after 24 h incubation at 20 °C [30]. This was done by a touch-provoked movement by which worms that reacted to the mechanical stimulus were scored as alive whereas non-responding worms were considered to be dead. The survival rate (SR) was calculated as a percentage: SR (%) = (N° of worms alive × 100)/Total worms in the well.

2.6. Measurement of Catalase (CAT) and Superoxide Dismutase (SOD) Activity

L1 larvae were incubated in E. coli OP50-seeded NGM (control) or NGM containing guarana (100 µg/mL) until L4 stage. This guarana concentration was selected as it was the lowest concentration increasing C. elegans survival in the stress-resistance assay. After incubation, for the protein extraction, worms were suspended in cold buffer (150 mM NaCl, 50 mM Tris-HCl pH 8, and 1% TWEEN 20 at 4 °C; all reagents from Sigma-Aldrich, St. Louis, MO, USA) and sonicated in a water bath sonicator for 5 min at 35 kHz (JP Selecta 3000683, J.P. Selecta, Barcelona, Spain). The concentration of total protein in homogenized worms was measured using BCA kit (Thermo Fisher Scientific, Waltham, MA, USA) and adjusted to the specifications of the CAT and SOD activity quantification kits (Cayman Chemicals, Ann Arbor, MI, USA), which were used for the CAT and SOD activity determination.

2.7. Quantification of Total Glutathione in C. elegans

For this assay, the protocol of Jenkins, et al. was followed [31] with some modifications. The worms were incubated in the same conditions as descried in Section 2.5, after which 50 adults per condition were collected in 200 µL of S-basal (5.85 g/L NaCl, 1 g/L K2HPO4, 6 g/L KH2PO4, 5 mg/L cholesterol; all reagents from Sigma-Aldrich, St. Louis, MO, USA) and transferred to 1.5 mL Eppendorf tubes. Two wash cycles were conducted with S- basal after which the worms were spun down and the total volume reduced to 20 µL. Later, a 50 µL aliquot of extraction buffer was added and the tubes were frozen in liquid nitrogen. The extraction buffer consisted of: 6 mg/mL 5-sulfosalicylic acid dehydrate, 0.1% v/v Triton X-100 and Complete, and Ethylenediaminetetraacetic acid (EDTA)-free Proteinase inhibitor cocktail in KPE buffer (0.1 M potassium phosphate buffer and 5 mM EDTA at pH 7.5). After freezing, the samples were homogenized in a water bath sonicator (Ultrasonic Cleaner 3800 water bath, Branson Ultrasonics, Danbury, CT, USA) at 35 kHz and cooled to 4 °C, using 10 cycles of 10 s. The samples were later centrifuged at 14,000× g at 4 °C and the supernatants collected.
For the measurement of the total glutathione (GSH) the protocol of [32] was followed. As such, 83.3 units/mL of glutathione reductase (GR; Sigma-Aldrich, St. Louis, MO, USA) was added to the sample with 666 μg/mL of 5.5-dithio-bis (2-nitrobenzoic acid) (DTNB; Sigma-Aldrich, St. Louis, MO, USA). After 30 s, 666 μg/mL of β- nicotinamide adenine dinucleotide phosphate (β-NADPH, Sigma-Aldrich, St. Louis, MO, USA) was added and the formation of 5′-thio-2-nitrobenzoic acid (TNB) chromophore product was recorded using a Multiskan Sky microplate spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA) at 412 nm.

2.8. Lifespan Analysis

Gravid adults of the C. elegans strain SS104 were used to lay eggs onto fresh NGM OP50 plates. Eggs rose at 15 °C until L3/L4 stage, due to temperature sensitivity of mutant phenotypes. Once this stage was reached, they were transferred to 25 °C incubation. After 24 h at 25 °C, C. elegans were transferred to five replicate plates for each condition. Effects on longevity of three different concentrations of guarana were measured in this analysis: 100, 250 and 500 µg/mL and NGM plates were used as a control. Animals were transferred to fresh plates after 7 and 14 days and scored for survival every 2 days [27]. Scoring method was the same used as for the oxidative stressed induced by juglone method. For the experiments with dead E. coli, the exact same protocol was followed, but before the transfer of the worms to the agar plates, the E. coli lawn was exposed to a UV light of 380 nm for 30 min.

2.9. Impact of Guarana on E. coli Viability

E. coli lawns were grown as described in Section 2.3 on NGM plates (control) and NGM plates containing 100, 250, and 500 µg/mL of guarana. After the incubation they were scraped and re-suspended in 1 mL of phosphate-buffered saline (PBS; 140 mM NaCl, pH 7.4). In order to assess the possible impact of guarana on the colony-forming units (CFU) of E. coli, serial dilutions of the suspensions (from 10−1 to 10−7) were then made in PBS and plated onto LB agar. The agar plates were incubated for 18 h and the colonies counted. Additionally, in order to measure the viability of the bacteria, 200 µL of each suspension was transferred into a 96-well plate (Thermo Scientific, Waltham, MA, USA), after which resazurin was added at concentration of 20 μM and incubated for 20 min at RT, 200 rpm. Then, the fluorescence was recorded (λexcitation = 560 nm and λemission = 590 nm) using a Varioskan LUX multimode microplate reader (Thermo Fisher Scientific, Waltham, MA, USA) [33].

2.10. E. coli Folate Extraction

An overnight defined media culture of E. coli in LB (Fisher BioReagents, Pittsburg, PA, USA) was seeded onto guarana agar plates (500 µg/mL) and NGM plates, and incubated at 25 °C for 4 days. For these experiments the peptone of the NGM was substituted by purified amino acids as described in [24]. Bacterial lawns were scraped from plates into Eppendorfs using M9 buffer and kept on ice. The bacterial concentration was assessed by optical density (OD) at 600 nm. Samples were concentrated in chilled microcentrifuge and pellets were snap frozen in liquid nitrogen. Pellets were thawed and resuspended in a volume of ice-cold 90% methanol and 10% folate extraction buffer (FEB: 50 mM HEPES, 50 mM CHES, 0.5% w/v ascorbic acid, 0.2 M Dithiothreitol, pH 7.85 with NaOH) in proportion to bacterial content (37.5 × OD600 × original solution volume). FEB was spiked with 10 nM methotrexate-Glu6 as an internal standard. Samples were vortexed vigorously and left on ice for 15 min before centrifugation in a cooled microcentrifuge (Thermo Scientific, Waltham, MA, USA) for 15 min at full speed. Supernatants were used for analysis.

2.11. Folate Liquid Chromatography -Tandem Mass Spectrometry (LC-MS/MS)Analysis

The detection of the folates was performed following the protocol of Maynard, et al. [34]. Briefly, the detection was done by multiple reaction monitoring (MRM) analysis using an SCIEX QTRAP 6500 instrument (Sciex, Framingham, MA, USA). MRM conditions for 5-Me-H4PteGlu3 and 5/10-CHO-H4PteGlu3 were optimized by infusion of standards into the instrument. The optimized conditions for –Glu3 folates were applied to other higher folates using MRM transitions described by [35]. Further confirmation of folate identity was performed by performing enhanced product ion scans of folates of interest and comparing the fragment spectra with known standards.
The QTRAP 6500 was operated in ESI+ mode and was interfaced with a Shimadzu Nexera UHPLC system (Thermo Scientific, Waltham, MA, USA). Samples were separated using a Thermo PA2 C18 column (2.2 µm, 2.1 mm × 100 mm; Thermo Scientific, Waltham, MA, USA) with a gradient of 0.1% formic acid in water (mobile phase A) and acetonitrile (mobile phase B). Samples were maintained at 4 °C and 2 µL aliquots were injected. The column was maintained at 40 °C with a flow rate of 200 µL/min, starting at 2% B, held for 2 min, with a linear gradient to 100% B at 7 min, held for 1 min, before a 7-min re-equilibration step at 2% B that was necessary for consistent retention times. The column eluate flow to the MS was controlled via the QTRAP switching valve, allowing analysis between 4 and 8 min to minimize instrument contamination. Folates were quantified with reference to external standards of 5-Me-H4PteGlu3 and 5/10-CHO-H4PteGlu3, purchased from Schircks (Zürich, Switzerland). The matrix effects were assessed by spiking of standards into extracted samples.
The percentage of folate production was calculated using the analyte peak area of the untreated control.

2.12. Statistical Analysis

The statistical tests were performed using GraphPad Prism v. 8.00. EC50 values were estimated by a non-linear regression. The statistical differences were always assessed against the untreated control with a Student’s t-test and p values under 0.05 were considered significant. For the lifespan data, statistical significance was determined using the Log-Rank and Wilcoxon tests [34].

3. Results

3.1. Chemical Characterization of the Guarana Extract

Based on the UPLC-PDA-MS analyses, five major compounds were tentatively identified, as shown in Table 1 and Figure 1. The first peak with protonated molecular ion [M + H]+ m/z 195.18 was identified as a xanthine alkaloid caffeine, as described by [36]. Other main compounds were identified as deprotonated ions [M − H]− belonging to flavan-3-ols or its oligomers: catechin (m/z 289.02), epicatechin (m/z 289.02) and A-type procyanidin dimers (m/z 575.06 and m/z 574.96), according to [37,38].

3.2. Antioxidant Activity In Vitro and In Vivo

The guarana extract showed itself to be a potent antioxidant, both in vitro (Table 2) and in vivo (Figure 2). With the DPPH assay, the radical scavenging capacity shown by guarana was comparable to the one obtained with the positive control utilized, the ascorbic acid (Table 2). The high scavenging of free radicals was likely achieved by the presence of polyphenols, such as epicatechin, for which EC50 was also within the same order of magnitude as the positive control (Table 2). The radical scavenging capacity of the extract was also patent in vivo, where the antioxidant enzymes superoxide dismutases (SOD) and catalase (CAT) were less active when C. elegans was exposed to the guarana extract (Supplementary Figure S1). In addition, guarana managed to significantly increase the resistance of C. elegans to the oxidative stress induced by juglone (Figure 2). After the exposure to a lethal dose of this pro-oxidant (150 µM), which reduced the survival of the control practically to zero, it was observed how all the tested concentrations of guarana managed to increase the survival rate (SR) when compared to the untreated control (p < 0.001 for all the tested concentrations). In addition, we tested if this increase in survival was due to an impact of guarana on the glutathione (GSH) system of the worm. However, guarana did not show an increase in the total GSH at any tested concentration (Figure S2).

3.3. Guarana Extract Increases C. elegans Lifespan

When the worms were maintained on live E. coli, the presence of guarana on NGM resulted in a significant extension in C. elegans lifespan, at all the tested concentrations, 100, 250 and 500 µg/mL (Figure 3a; p < 0.001 in all the cases when compared to the untreated control). These effects seemed to be concentration dependent, as the life extension achieved with the highest concentration (500 µg/mL) was significantly higher than the one achieved with the lowest concentration used (100 µg/mL) (p = 0.003 when comparing these two concentrations with a log-rank test). We hypothesized that these effects may not only be given through the impact of guarana on the worms, but through the induced changes on the metabolites production of E. coli, which, as previously reported, might have a great impact on C. elegans survival. Therefore, to test the possibility of guarana affecting C. elegans lifespan by altering E. coli metabolism, we assessed its effects utilizing UV-killed E. coli (Figure 3b). In concordance with previous results, feeding the worms with non-viable bacteria increased the worm lifespan when compared to those fed with live bacteria (p < 0.001 when comparing the untreated controls, Figure S3) [25]. In these settings, the highest concentrations tested, 500 µg/mL, maintained the effect of prolonging C. elegans lifespan (p < 0.001 when compared to the untreated control). The concentration of 250 µg/mL still managed to extend the lifespan, but this extension was not as significant as the one achieved with live E. coli (p = 0.0011, when compared to the untreated control) and the concentration of 100 µg/mL did not show any differences with the untreated control. Overall, it seemed that the impact of guarana on extending lifespan was not as intense when the bacteria were not metabolically active. In Table 3, it can be clearly observed how the effects of guarana on life extension are not proportional when comparing the two different scenarios (alive and dead E. coli). For instance, at the highest concentration (500 µg/mL), the average lifespan with live E. coli was four and a half days longer than the control, while with dead E. coli, this extension was only two days.
In order to discard that the life extension observed with live E. coli (Figure 3a) was given due to a potential antimicrobial effect of guarana, we measured the viability of the bacteria and its growth on NGM with different concentrations of guarana. Via resazurin staining, we did not observe any reduction in the bacteria viability and the number of CFUs was not reduced at any of the tested concentrations (Figure S4).

3.4. Guarana Extract Reduces the Folate Production of E. coli

To analyze the impact of guarana on E. coli folate synthesis, we used LC-MS/MS to detect levels of individual E. coli tetrahydrofolates (THFs). It has been previously observed that 5-methyl THF-glu3 and 5/10-formyl THF-glu3 are among the most abundant folate species detected in E. coli grown in NGM [27,34]. Because of this, we decided to assess the impact of guarana on the production of these two THFs species. In Figure 4, it can be seen how the presence of guarana in NGM produced a significant reduction in E. coli production of 5-methyl-tetrahydrofolate and 10-formyl-tetrahydrofolate (p < 0.001 in both cases).

4. Discussion

The chemical profile of the guarana extract used in this study agreed with the one previously described in the literature. As expected, caffeine was present in the extract, as among plant species containing this alkaloid, guarana has the highest content [39]. On the other hand, the phenolic compounds found, catechin, epicatechin, and A-type procyanidin dimer, are also often detected in guarana, despite its content possibly varying, depending on the geographical location of the plant [37,40].
In agreement with previously reported results, guarana showed a high antioxidant activity in vitro [41,42,43,44,45,46]. It is not surprising that the radical scavenging capacity of the extract was so high, given the known hydrogen and electron-donating ability of polyphenols [47]. For instance, the presence of epicatechin, which showed an EC50 of 11.55 ± 2.23 µg/mL, might have highly contributed to the antioxidant activity of the extract. Interestingly, the EC50 obtained with our extract (4.696 to 8.747 µg/mL) was almost 10-times smaller than the one obtained by the guarana aqueous extract utilized by Peixoto, et al. [48] (40 µg/mL), while the EC50 calculated for the positive control (ascorbic acid) was the same in both studies (~2 µg/mL). The high capacity of guarana in scavenging free radicals was also patent in vivo, given that the activity of two of the major antioxidant enzymes, CAT and SOD [49], was significantly lower when the worms were exposed to the guarana extract (Figure S1). During the treatment with guarana, there is possibly a decrease in the basal levels of free radicals, which might have resulted in a down-regulation of the cellular enzymatic antioxidant defense [50].
In line with our results, Peixoto, et al.[48] also reported an increased resistance in C. elegans treated with guarana to the pro-oxidant juglone (Figure 2). These authors showed that when using mutant worms lacking the daf-16 gene, the treatment with guarana did not increase the survival rate, which could point towards an impact of guarana on the regulation of the stress resistance machinery in the worm. DAF-16 regulates the expression of several genes involved in stress resistance and longevity in C. elegans, being a homologue of the mammalian FOXO transcription factor [51]. Nevertheless, C. elegans is able to counteract oxidative stress through other pathways, such as those within the thiol redox network [52]. For instance, SKN-1, which is an orthologue of the human Nrf2, controls the regulation of genes encoding anti-oxidant enzymes, such as glutathione-S-transferase [53]. In order to assess if guarana additionally has an impact on the glutathione (GSH) system of the worm, we measured the impact of this extract on GSH pools, before and after exposure to juglone. However, no differences were found at any of the tested concentrations of guarana, while the treatment with juglone caused a decrease in total GSH levels, as expected (Figure S2) [52]. Therefore, we concluded that the antioxidant activity of guarana is not partly given through the regulation of the GSH system.
The guarana extract included in our study significantly extended C. elegans lifespan, at all tested concentrations (Figure 3a), which was in agreement with previous results [19,48]. Arantes, et al. concluded that the extension in lifespan produced by guarana was mediated by antioxidant activity and HSF-1, SKN-1, and DAF-16 pathways. Besides, they also demonstrated its effects through ADOR-1, which might indicate the involvement of the pyrogenic system in longevity [19]. These authors aptly suggested that the life-expanding effects of guarana might be related to the synergistic effects of the different compounds present in it, which influence the lifespan through different pathways. For instance, caffeine, also identified in our extract, has been proven to extend C. elegans lifespan, independently of DAF-16 and SKN-1 regulation [54]. Our results indicated that not only the synergy between the different compounds would prolong C. elegans lifespan, but also the combination of the direct effects of guarana on the worms and this extract’s indirect effects through its impact on E. coli metabolism. As shown in Figure 3b, when C. elegans was fed with dead E. coli, the impact on lifespan was not as significant as the one achieved with metabolically active bacteria.
In recent years, it has become obvious that the microbiota have an impact on the health status of the host, including the aging process. The differences in gut microbiota composition between elderly and younger populations have been extensively proven. However, it is yet unknown if these differences are just the consequences of the changes in host physiology and diet, or if microbes could actually accelerate the aging of the host [12]. It is difficult to establish if the different changes in the microbiota are causative rather than consequential, but one of the strongest effector candidates are microbial metabolites [55]. These could act as signaling molecules to modulate the host metabolism, impact its energy balance, and potentially promote inflammation [55]. This raises the question whether nutraceuticals, such as guarana, could impact aging and pathological processes via their effects on the phenotype and metabolism of our gut microbiota.
C. elegans has proven to be an ideal model to assess the indirect impact of orally administrated drugs on aging via their interactions with the bacterial metabolism. For instance, it was shown how metformin, or sulfamethoxazole increased C. elegans lifespan via the reduction in E. coli folate production [24]. For this reason, we hypothesized that guarana might have extended the worm lifespan, not only due to its antioxidant capacity but also by reducing the folate production of E. coli, and, indeed, we found out that it significantly reduces the production of 5-methyl THF-glu3 and 5/10-formyl THF-glu3 (Figure 4).
The process by which the inhibition of folate synthesis prevents bacteria from accelerating ageing is still unknown. Nevertheless, it has been hypothesized by other authors that E. coli shortens C. elegans lifespan through a form of toxin-based virulence, and that in bacteria, folate has functions beyond its role in biosynthetic one-carbon metabolism [24]. However, it is known that the different folate forms do not cause any effects on C. elegans lifespan per se [24].
In humans, aging, as well as chronic conditions, such as obesity and Crohn’s disease, are characterized by a dysbiosis of the microbiota, distinguished by an increase in proteobacteria, such as E. coli [56], which, as mentioned in the introduction, may cause folate-dependent toxicity [13,14]. Interestingly, drugs, such as sulfasalazine, which target bacterial folate synthesis, have proven efficacy treating Crohn’s diseases and ulcerative colitis [57]. Therefore, according to the data obtained here, guarana could potentially represent an interesting diet supplement for these pathologies, owing to its ability to reduce bacterial folate production. Moreover, despite the fact that it remains to be determined whether inhibiting bacterial folate synthesis would slow aging in humans, the combination of guarana’s antioxidant capacity and its inhibition of bacterial folate synthesis seem to make it an interesting anti-aging nutraceutical.
It has to be additionally taken into account that micronutrients, such as folate, can be obtained from the bacterial microbiota but also directly from the diet [16]. Specifically, vitamin B9 or folate is one of the most commonly supplemented vitamins, as it has been proven to prevent or ameliorate the symptoms associated with its deficiency, such as congenial birth defects [58]. However, in the dosage paradigm, the bacterial folate production and its assimilation into host tissues should be taken into account [16]. This non-predicted source of folate could result in adverse effects, such as zinc deficiency or even an increased risk of colorectal cancer [59,60]. Therefore, given the potential risks of both folate deficiency and excess, it would be interesting to be able to predict the impact of other diet components, such as guarana, in its physiological levels.
With this study, we managed to further characterize the properties of guarana, confirming its antioxidant and anti-aging capacity, and providing new information on its impact on E. coli metabolism. According to the data obtained, the weaker improvement in the lifespan observed in the presence of dead bacteria could be an outcome of the direct beneficial effects of the guarana extract on C. elegans. Based on the existing literature and our own results, the antioxidant properties of guarana have a significant role in them. With the current data, we cannot give categorical assurance that the effect observed in the animals fed with dead E. coli is due exclusively to the antioxidant effect of the extract or corresponds to the net benefit of its antioxidant effect in the model. In order to clarify this, as part of future work, we will utilize daf-16 and skn-1-deficient mutants to assess the impact of guarana on C. elegans lifespan, fed with metabolically inactive E. coli. In addition, we plan to determine whether it is one of the major components of guarana responsible for the inhibition of bacterial folate production or if the obtained results are the consequence of the synergistic activity of the complex composition of this plant extract.
Guarana has been extensively studied, and many of its granted properties count with a scientific background; however, there is still hardly any literature on its impact on the gut microbiota [61]. As far as we know, this is the first study showing how the effects of guarana on bacterial metabolism have a direct impact on C. elegans survival. The identified capacity of guarana inhibiting bacterial folate production could make it an interesting co-adjuvant in the treatment of intestinal pathologies, characterized by microbiota dysbiosis and increased microbial-derived folate levels. Moreover, given that folate can be directly obtained from diet, bacterial folate synthesis could be targeted without compromising the folate status of the host [24].
Finally, we proved the utility of C. elegans as a model to study the potential impact of nutraceuticals on the host health, both directly and indirectly, through their potential impact on bacterial metabolism.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/nu14091986/s1, Figure S1. Impact of guarana (100 μg/mL) on the catalase (CAT) (a) and superoxide dismutase (SOD) (b) activity of C. elegans (N2), Figure S2. Glutathione (GSH) production of C. elegans (N2) when treated with different concentrations of guarana (25, 50, 100, 250 and 500 μg/mL), Figure S3. Percentage of survival of SS104 glp-4 animals (25 °C) fed with alive (n = 125) or dead E. coli OP 50 (n = 115), Figure S4. Effects of different concentrations (100, 250 and 500 µg/mL) of guarana on the viable colony counts (a) and the viability (b) of E. coli.

Author Contributions

Conceptualization, C.G.-R., E.L. and L.H.; methodology, I.R., C.M., K.K. and D.W.; software, I.R.; validation, I.R.; formal analysis, I.R.; investigation, I.R. and K.K.; resources, C.G.-R., E.L., L.H. and D.W.; data curation, I.R.; writing—original draft preparation, I.R.; writing—review and editing, C.G.-R., E.L., K.K., M.S.V., C.M., D.W. and L.H.; visualization, I.R.; supervision, M.S.V., C.G.-R., E.L., L.H. and D.W.; project administration, C.G.-R. and L.H.; funding acquisition, C.G.-R. and L.H. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by an Academy of Finland grant 333291 to LH and open access funding provided by University of Helsinki.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Acknowledgments

The authors thank Timo Oksanen from the Faculty of Pharmacy, University of Helsinki, for great help in UPLC-MS-PDA analyses.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Dwyer, J.T.; Coates, P.M.; Smith, M.J. Dietary Supplements: Regulatory Challenges and Research Resources. Nutrients 2018, 10, 41. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Smith, N.; Atroch, A.L. Guaraná’s Journey from Regional Tonic to Aphrodisiac and Global Energy Drink. Evid.-Based Complement. Altern. Med. 2010, 7, 279–282. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Patrick, M.; Kim, H.A.; Oketch-Rabah, H.; Marles, R.J.; Roe, A.L.; Calderón, A.I. Safety of Guarana Seed as a Dietary Ingredient: A Review. J. Agric. Food Chem. 2019, 67, 11281–11287. [Google Scholar] [CrossRef]
  4. Kola, P.; Metowogo, K.; Manjula, S.N.; Katawa, G.; Elkhenany, H.; Mruthunjaya, K.M.; Eklu-Gadegbeku, K.; Aklikokou, K.A. Ethnopharmacological evaluation of antioxidant, anti-angiogenic, and anti-inflammatory activity of some traditional medicinal plants used for treatment of cancer in Togo/Africa. J. Ethnopharmacol. 2022, 283, 114673. [Google Scholar] [CrossRef] [PubMed]
  5. Ruchel, J.B.; Bernardes, V.M.; Braun, J.B.S.; Manzoni, A.G.; Passos, D.F.; Castilhos, L.G.; Abdalla, F.H.; de Oliveira, J.S.; de Andrade, C.M.; Casali, E.A.; et al. Lipotoxicity-associated inflammation is prevented by guarana (Paullinia cupana) in a model of hyperlipidemia. Drug Chem. Toxicol. 2021, 44, 524–532. [Google Scholar] [CrossRef] [PubMed]
  6. Veloso, C.F.; Machado, A.K.; Cadoná, F.C.; Azzolin, V.F.; Cruz, I.B.M.; Silveira, A.F. Neuroprotective Effects of Guarana (Paullinia cupana Mart.) against Vincristine in Vitro Exposure. J. Prev. Alzheimers Dis. 2018, 5, 65–70. [Google Scholar] [CrossRef] [PubMed]
  7. De Araujo, D.P.; Pereira, P.; Fontes, A.J.C.; Marques, K.D.S.; de Moraes, É.B.; Guerra, R.N.M.; Garcia, J.B.S. The use of guarana (Paullinia cupana) as a dietary supplement for fatigue in cancer patients: A systematic review with a meta-analysis. Support. Care Cancer 2021, 29, 7171–7182. [Google Scholar] [CrossRef]
  8. Ruchel, J.B.; Rezer, J.F.; Thorstenberg, M.L.; Dos Santos, C.B.; Cabral, F.L.; Lopes, S.T.; da Silva, C.B.; Machado, A.K.; da Cruz, I.B.; Schetinger, M.R.; et al. Hypercholesterolemia and Ecto-enzymes of Purinergic System: Effects of Paullinia cupana. Phytother. Res. 2016, 30, 49–57. [Google Scholar] [CrossRef]
  9. Torres, E.; Pinaffi-Langley, A.; Figueira, M.S.; Cordeiro, K.S.; Negrão, L.D.; Soares, M.J.; da Silva, C.P.; Alfino, M.C.Z.; Sampaio, G.R.; de Camargo, A.C. Effects of the consumption of guarana on human health: A narrative review. Compr. Rev. Food Sci. Food Saf. 2022, 21, 272–295. [Google Scholar] [CrossRef]
  10. Krewer Cda, C.; Ribeiro, E.E.; Ribeiro, E.A.; Moresco, R.N.; da Rocha, M.I.; Montagner, G.F.; Machado, M.M.; Viegas, K.; Brito, E.; da Cruz, I.B. Habitual intake of guaraná and metabolic morbidities: An epidemiological study of an elderly Amazonian population. Phytother. Res. 2011, 25, 1367–1374. [Google Scholar] [CrossRef]
  11. Yilmaz, L.S.; Walhout, A.J. Worms, bacteria, and micronutrients: An elegant model of our diet. Trends Genet. 2014, 30, 496–503. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  12. Maynard, C.; Weinkove, D. The Gut Microbiota and Ageing. Sub-Cell. Biochem. 2018, 90, 351–371. [Google Scholar] [CrossRef]
  13. Camilo, E.; Zimmerman, J.; Mason, J.B.; Golner, B.; Russell, R.; Selhub, J.; Rosenberg, I.H. Folate synthesized by bacteria in the human upper small intestine is assimilated by the host. Gastroenterology 1996, 110, 991–998. [Google Scholar] [CrossRef] [PubMed]
  14. Dukowicz, A.C.; Lacy, B.E.; Levine, G.M. Small intestinal bacterial overgrowth: A comprehensive review. Gastroenterol. Hepatol. 2007, 3, 112–122. [Google Scholar]
  15. Fan, Y.; Pedersen, O. Gut microbiota in human metabolic health and disease. Nat. Rev. Microbiol. 2021, 19, 55–71. [Google Scholar] [CrossRef]
  16. Maynard, C.; Weinkove, D. Bacteria increase host micronutrient availability: Mechanisms revealed by studies in C. elegans. Genes Nutr. 2020, 15, 4. [Google Scholar] [CrossRef] [Green Version]
  17. Shen, P.; Yue, Y.; Park, Y. A living model for obesity and aging research: Caenorhabditis elegans. Crit. Rev. Food Sci. Nutr. 2018, 58, 741–754. [Google Scholar] [CrossRef]
  18. Papaevgeniou, N.; Chondrogianni, N. Anti-aging and Anti-aggregation Properties of Polyphenolic Compounds in C. elegans. Curr. Pharm. Des. 2018, 24, 2107–2120. [Google Scholar] [CrossRef]
  19. Arantes, L.P.; Machado, M.L.; Zamberlan, D.C.; da Silveira, T.L.; da Silva, T.C.; da Cruz, I.B.M.; Ribeiro, E.E.; Aschner, M.; Soares, F.A.A. Mechanisms involved in anti-aging effects of guarana (Paullinia cupana) in Caenorhabditis elegans. Braz. J. Med. Biol. Res. 2018, 51, e7552. [Google Scholar] [CrossRef]
  20. Boasquívis, P.F.; Silva, G.M.M.; Paiva, F.A.; Cavalcanti, R.M.; Nunez, C.V.; de Paula Oliveira, R. Guarana (Paullinia cupana) Extract Protects Caenorhabditis elegans Models for Alzheimer Disease and Huntington Disease through Activation of Antioxidant and Protein Degradation Pathways. Oxid. Med. Cell Longev. 2018, 2018, 9241308. [Google Scholar] [CrossRef] [Green Version]
  21. Zamberlan, D.C.; Arantes, L.P.; Machado, M.L.; da Silveira, T.L.; da Silva, A.F.; da Cruz, I.B.M.; Figueiredo, C.P.; Soares, F.A.A. Guarana (Paullinia cupana Mart.) protects against amyloid-β toxicity in Caenorhabditis elegans through heat shock protein response activation. Nutr. Neurosci. 2020, 23, 444–454. [Google Scholar] [CrossRef] [PubMed]
  22. Backes, C.; Martinez-Martinez, D.; Cabreiro, F. C. elegans: A biosensor for host-microbe interactions. Lab Anim. 2021, 50, 127–135. [Google Scholar] [CrossRef] [PubMed]
  23. Kim, D.H.; Flavell, S.W. Host-microbe interactions and the behavior of Caenorhabditis elegans. J. Neurogenet. 2020, 34, 500–509. [Google Scholar] [CrossRef]
  24. Virk, B.; Jia, J.; Maynard, C.A.; Raimundo, A.; Lefebvre, J.; Richards, S.A.; Chetina, N.; Liang, Y.; Helliwell, N.; Cipinska, M.; et al. Folate Acts in E. coli to Accelerate C. elegans Aging Independently of Bacterial Biosynthesis. Cell Rep. 2016, 14, 1611–1620. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Cabreiro, F.; Au, C.; Leung, K.Y.; Vergara-Irigaray, N.; Cochemé, H.M.; Noori, T.; Weinkove, D.; Schuster, E.; Greene, N.D.; Gems, D. Metformin retards aging in C. elegans by altering microbial folate and methionine metabolism. Cell 2013, 153, 228–239. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Mendoza, L.; Yanez, K.; Vivanco, M.; Melo, R.; Cotoras, M. Characterization of extracts from winery by-products with antifungal activity against Botrytis cinerea. Ind. Crops Prod. 2013, 43, 360–364. [Google Scholar] [CrossRef]
  27. Virk, B.; Correia, G.; Dixon, D.P.; Feyst, I.; Jia, J.; Oberleitner, N.; Briggs, Z.; Hodge, E.; Edwards, R.; Ward, J.; et al. Excessive folate synthesis limits lifespan in the C. elegans: E. coli aging model. BMC Biol. 2012, 10, 67. [Google Scholar] [CrossRef] [Green Version]
  28. Lopez, V.; Akerreta, S.; Casanova, E.; Garcia-Mina, J.M.; Cavero, R.Y.; Calvo, M.I. In vitro antioxidant and anti-rhizopus activities of lamiaceae herbal extracts. Plant Food Hum. Nutr. 2007, 62, 151–155. [Google Scholar] [CrossRef]
  29. Brand-Williams, W.; Cuvelier, M.E.; Berset, C. Use of a free radical method to evaluate antioxidant activity. Food Sci. Technol. 1995, 28, 25–30. [Google Scholar] [CrossRef]
  30. Reigada, I.; Moliner, C.; Valero, M.S.; Weinkove, D.; Langa, E.; Gomez Rincon, C. Antioxidant and Antiaging Effects of Licorice on the Caenorhabditis elegans Model. J. Med. Food 2019, 23, 1. [Google Scholar] [CrossRef]
  31. Jenkins, N.L.; James, S.A.; Salim, A.; Sumardy, F.; Speed, T.P.; Conrad, M.; Richardson, D.R.; Bush, A.I.; McColl, G. Changes in ferrous iron and glutathione promote ferroptosis and frailty in aging Caenorhabditis elegans. eLife 2020, 9, e56580. [Google Scholar] [CrossRef] [PubMed]
  32. Kortesoja, M.; Karhu, E.; Olafsdottir, E.S.; Freysdottir, J.; Hanski, L. Impact of dibenzocyclooctadiene lignans from Schisandra chinensis on the redox status and activation of human innate immune system cells. Free Radic. Biol. Med. 2019, 131, 309–317. [Google Scholar] [CrossRef] [PubMed]
  33. Reigada, I.; Perez-Tanoira, R.; Patel, J.Z.; Savijoki, K.; Yli-Kauhaluoma, J.; Kinnari, T.J.; Fallarero, A. Strategies to Prevent Biofilm Infections on Biomaterials: Effect of Novel Naturally-Derived Biofilm Inhibitors on a Competitive Colonization Model of Titanium by Staphylococcus aureus and SaOS-2 Cells. Microorganisms 2020, 8, 345. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Maynard, C.; Cummins, I.; Green, J.; Weinkove, D. A bacterial route for folic acid supplementation. BMC Biol. 2018, 16, 67. [Google Scholar] [CrossRef] [Green Version]
  35. Lu, W.; Kwon, Y.K.; Rabinowitz, J.D. Isotope ratio-based profiling of microbial folates. J. Am. Soc. Mass Spectrom. 2007, 18, 898–909. [Google Scholar] [CrossRef] [Green Version]
  36. Ushirobira, T.M.A.; Yamaguti, E.; Uemura, L.M.; Nakamura, C.V.; Dias, B.P.; de Mello, J.C.P. Chemical and Microbiological Study of Extract from Seeds of Guaraná (Paullinia cupana var. sorbilis). Lat. Am. J. Pharm. 2007, 26, 5–9. [Google Scholar]
  37. Da Silva, G.S.; Canuto, K.M.; Ribeiro, P.R.V.; de Brito, E.S.; Nascimento, M.M.; Zocolo, G.J.; Coutinho, J.P.; de Jesus, R.M. Chemical profiling of guarana seeds (Paullinia cupana) from different geographical origins using UPLC-QTOF-MS combined with chemometrics. Food Res. Int. 2017, 102, 700–709. [Google Scholar] [CrossRef]
  38. Silva, M.P.; Thomazini, M.; Holkem, A.T.; Pinho, L.S.; Genovese, M.I.; Fávaro-Trindade, C.S. Production and characterization of solid lipid microparticles loaded with guaraná (Paullinia cupana) seed extract. Food Res. Int. 2019, 123, 144–152. [Google Scholar] [CrossRef]
  39. Schimpl, F.C.; Kiyota, E.; Mazzafera, P. Production of Recombinant Caffeine Synthase from Guarana (Paullinia cupana var. sorbilis) in Escherichia coli. Methods Mol. Biol. 2016, 1405, 49–57. [Google Scholar] [CrossRef]
  40. Yamaguti-Sasaki, E.; Ito, L.A.; Canteli, V.C.; Ushirobira, T.M.; Ueda-Nakamura, T.; Dias Filho, B.P.; Nakamura, C.V.; de Mello, J.C. Antioxidant capacity and in vitro prevention of dental plaque formation by extracts and condensed tannins of Paullinia cupana. Molecules 2007, 12, 1950–1963. [Google Scholar] [CrossRef] [Green Version]
  41. Pateiro, M.; Vargas, F.C.; Chincha, A.A.I.A.; Sant’Ana, A.S.; Strozzi, I.; Rocchetti, G.; Barba, F.J.; Domínguez, R.; Lucini, L.; do Amaral Sobral, P.J.; et al. Guarana seed extracts as a useful strategy to extend the shelf life of pork patties: UHPLC-ESI/QTOF phenolic profile and impact on microbial inactivation, lipid and protein oxidation and antioxidant capacity. Food Res. Int. 2018, 114, 55–63. [Google Scholar] [CrossRef] [PubMed]
  42. Belló, C.; Prestes, A.P.; Schemberger, J.A.; Hacke, A.C.M.; Pereira, R.P.; Manente, F.A.; Carlos, I.Z.; de Andrade, C.R.; Fernandes, D.; da Cruz, I.B.M.; et al. Aqueous extract of Paullinia cupana attenuates renal and hematological effects associated with ketoprofen. J. Food Biochem. 2021, 45, e13560. [Google Scholar] [CrossRef] [PubMed]
  43. Machado, K.N.; Paula Barbosa, A.; de Freitas, A.A.; Alvarenga, L.F.; Pádua, R.M.; Gomes Faraco, A.A.; Braga, F.C.; Vianna-Soares, C.D.; Castilho, R.O. TNF-α inhibition, antioxidant effects and chemical analysis of extracts and fraction from Brazilian guaraná seed powder. Food Chem. 2021, 355, 129563. [Google Scholar] [CrossRef] [PubMed]
  44. Mattei, R.; Dias, R.F.; Espínola, E.B.; Carlini, E.A.; Barros, S.B. Guarana (Paullinia cupana): Toxic behavioral effects in laboratory animals and antioxidants activity in vitro. J. Ethnopharmacol. 1998, 60, 111–116. [Google Scholar] [CrossRef]
  45. Sereia, A.L.; de Oliveira, M.T.; Baranoski, A.; Marques, L.L.M.; Ribeiro, F.M.; Isolani, R.G.; de Medeiros, D.C.; Chierrito, D.; Lazarin-Bidóia, D.; Zielinski, A.A.F.; et al. In vitro evaluation of the protective effects of plant extracts against amyloid-beta peptide-induced toxicity in human neuroblastoma SH-SY5Y cells. PLoS ONE 2019, 14, e0212089. [Google Scholar] [CrossRef]
  46. Hamerski, L.; Somner, G.V.; Tamaio, N.J. Paullinia cupana Kunth (Sapindaceae): A review of its ethnopharmacology, phytochemistry and pharmacology. J. Med. Plants Res. 2013, 7, 2221–2229. [Google Scholar]
  47. Lee, C.Y.; Nanah, C.N.; Held, R.A.; Clark, A.R.; Huynh, U.G.T.; Maraskine, M.C.; Uzarski, R.L.; McCracken, J.; Sharma, A. Effect of electron donating groups on polyphenol-based antioxidant dendrimers. Biochimie 2015, 111, 125–134. [Google Scholar] [CrossRef] [Green Version]
  48. Peixoto, H.; Roxo, M.; Röhrig, T.; Richling, E.; Wang, X.; Wink, M. Anti-Aging and Antioxidant Potential of Paullinia cupana var. sorbilis: Findings in Caenorhabditis elegans Indicate a New Utilization for Roasted Seeds of Guarana. Medicines 2017, 4, 61. [Google Scholar] [CrossRef]
  49. Ayuda-Durán, B.; González-Manzano, S.; González-Paramás, A.M.; Santos-Buelga, C. Caernohabditis elegans as a Model Organism to Evaluate the Antioxidant Effects of Phytochemicals. Molecules 2020, 25, 3194. [Google Scholar] [CrossRef]
  50. Zeidán-Chuliá, F.; Gelain, D.P.; Kolling, E.A.; Rybarczyk-Filho, J.L.; Ambrosi, P.; Terra, S.R.; Pires, A.S.; da Rocha, J.B.; Behr, G.A.; Moreira, J.C. Major components of energy drinks (caffeine, taurine, and guarana) exert cytotoxic effects on human neuronal SH-SY5Y cells by decreasing reactive oxygen species production. Oxid. Med. Cell Longev. 2013, 2013, 791795. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  51. Hesp, K.; Smant, G.; Kammenga, J.E. Caenorhabditis elegans DAF-16/FOXO transcription factor and its mammalian homologs associate with age-related disease. Exp. Gerontol. 2015, 72, 1–7. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  52. Ahmad, T.; Suzuki, Y.J. Juglone in Oxidative Stress and Cell Signaling. Antioxidants 2019, 8, 91. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  53. Ferguson, G.D.; Bridge, W.J. The glutathione system and the related thiol network in Caenorhabditis elegans. Redox. Biol. 2019, 24, 101171. [Google Scholar] [CrossRef]
  54. Li, H.; Roxo, M.; Cheng, X.; Zhang, S.; Cheng, H.; Wink, M. Pro-oxidant and lifespan extension effects of caffeine and related methylxanthines in Caenorhabditis elegans. Food Chem. X 2019, 1, 100005. [Google Scholar] [CrossRef] [PubMed]
  55. O’Toole, P.W.; Jeffery, I.B. Microbiome-health interactions in older people. Cell. Mol. Life Sci. 2018, 75, 119–128. [Google Scholar] [CrossRef] [PubMed]
  56. Winter, S.E.; Bäumler, A.J. Dysbiosis in the inflamed intestine: Chance favors the prepared microbe. Gut Microbes 2014, 5, 71–73. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  57. Peppercorn, M.A. Advances in drug therapy for inflammatory bowel disease. Ann. Intern. Med. 1990, 112, 50–60. [Google Scholar] [CrossRef]
  58. Bibbins-Domingo, K.; Grossman, D.C.; Curry, S.J.; Davidson, K.W.; Epling, J.W., Jr.; García, F.A.; Kemper, A.R.; Krist, A.H.; Kurth, A.E.; Landefeld, C.S.; et al. Folic Acid Supplementation for the Prevention of Neural Tube Defects: US Preventive Services Task Force Recommendation Statement. JAMA 2017, 317, 183–189. [Google Scholar] [CrossRef]
  59. Cole, B.F.; Baron, J.A.; Sandler, R.S.; Haile, R.W.; Ahnen, D.J.; Bresalier, R.S.; McKeown-Eyssen, G.; Summers, R.W.; Rothstein, R.I.; Burke, C.A.; et al. Folic acid for the prevention of colorectal adenomas: A randomized clinical trial. JAMA 2007, 297, 2351–2359. [Google Scholar] [CrossRef]
  60. Milne, D.B.; Canfield, W.K.; Mahalko, J.R.; Sandstead, H.H. Effect of oral folic acid supplements on zinc, copper, and iron absorption and excretion. Am. J. Clin. Nutr. 1984, 39, 535–539. [Google Scholar] [CrossRef]
  61. Kleber Silveira, A.; Moresco, K.S.; Mautone Gomes, H.; da Silva Morrone, M.; Kich Grun, L.; Pens Gelain, D.; de Mattos Pereira, L.; Giongo, A.; Rodrigues De Oliveira, R.; Fonseca Moreira, J.C. Guarana (Paullinia cupana Mart.) alters gut microbiota and modulates redox status, partially via caffeine in Wistar rats. Phytother. Res. 2018, 32, 2466–2474. [Google Scholar] [CrossRef] [PubMed]
Nutrients 14 01986 g001 550
Figure 1. UV Max plot chromatogram of guarana seed extract at 0.0–4.0 min. Key: 1, caffeine; 2, catechin; 3, epicatechin; 4, A-type procyanidin dimer; 5, A-type procyanidin dimer. AU = absorbance units.
Figure 1. UV Max plot chromatogram of guarana seed extract at 0.0–4.0 min. Key: 1, caffeine; 2, catechin; 3, epicatechin; 4, A-type procyanidin dimer; 5, A-type procyanidin dimer. AU = absorbance units.
Nutrients 14 01986 g001
Nutrients 14 01986 g002 550
Figure 2. Survival Rate (SR) (%) of C. elegans after juglone-induced oxidative stress. The different populations were treated with different concentrations of guarana 100 (n = 431), 250 (n = 405) and 500 (n = 321) µg/mL prior to juglone challenge. Non-treated populations were used as control (n = 438). Data are presented as the mean and SEM of survival percentage (*** p < 0.0001; Student’s t-test).
Figure 2. Survival Rate (SR) (%) of C. elegans after juglone-induced oxidative stress. The different populations were treated with different concentrations of guarana 100 (n = 431), 250 (n = 405) and 500 (n = 321) µg/mL prior to juglone challenge. Non-treated populations were used as control (n = 438). Data are presented as the mean and SEM of survival percentage (*** p < 0.0001; Student’s t-test).
Nutrients 14 01986 g002
Nutrients 14 01986 g003 550
Figure 3. (a) Percentage of survival of SS104 glp-4 animals (25 °C) fed with live E. coli OP50 and treated with different concentrations of guarana, 100 (n = 120), 250 (n = 119) and 500 (n = 111) µg/mL compared with the control (n = 125). (b) Percentage of survival of SS104 glp-4 animals (25 °C) fed with dead E. coli OP50 and treated with different concentration of guarana, 100 (n = 98), 250 (n = 120) and 500 (n = 111) µg/mL compared with the control (n = 115). Results are expressed as mean ± SD.
Figure 3. (a) Percentage of survival of SS104 glp-4 animals (25 °C) fed with live E. coli OP50 and treated with different concentrations of guarana, 100 (n = 120), 250 (n = 119) and 500 (n = 111) µg/mL compared with the control (n = 125). (b) Percentage of survival of SS104 glp-4 animals (25 °C) fed with dead E. coli OP50 and treated with different concentration of guarana, 100 (n = 98), 250 (n = 120) and 500 (n = 111) µg/mL compared with the control (n = 115). Results are expressed as mean ± SD.
Nutrients 14 01986 g003
Nutrients 14 01986 g004 550
Figure 4. Guarana (500 µg/mL) effects on the E. coli production of two folate forms, (a) 5-methyl THF-glu3 (5-CH3-H4PteGlu3) and (b) 5/10-formyl THF-glu3 (10-CHO-H4PteGlu3). Data are presented as the mean and SD of the percentage of folate production of five replicates (*** p < 0.0001).
Figure 4. Guarana (500 µg/mL) effects on the E. coli production of two folate forms, (a) 5-methyl THF-glu3 (5-CH3-H4PteGlu3) and (b) 5/10-formyl THF-glu3 (10-CHO-H4PteGlu3). Data are presented as the mean and SD of the percentage of folate production of five replicates (*** p < 0.0001).
Nutrients 14 01986 g004
Table
Table 1. Compounds tentatively identified in the guarana seeds extract by UPLC-PDA-MS analyses.
Table 1. Compounds tentatively identified in the guarana seeds extract by UPLC-PDA-MS analyses.
Peak No.Retention Time (min)[M − H]−[M + H]+Product IonsIdentified Compounds
[M − H]−[M + H]+
10.64 195.18 Caffeine
21.00289.02 245.00; 203.07; 587.16; 449.06 Catechin
31.15289.02 203.04; 245.00; 220.95; 587.06; 449.01 Epicatechin
41.26575.06 289.03; 284.89; 449.18; 539.11; 557.03; 575.88 A-type procyanidin dimer
51.65574.96 289.00; 575.68; 285.08; 449.00; 423.06; 407.38 A-type procyanidin dimer
Table
Table 2. In vitro antioxidant activity of guarana and epicatechin compared to a positive control, ascorbic acid.
Table 2. In vitro antioxidant activity of guarana and epicatechin compared to a positive control, ascorbic acid.
SampleEC50 (µg/mL)
Guarana extract4.696 to 8.747
Epicatechin9.320 to 13.780
Ascorbic acid1.719 to 2.021
Table
Table 3. Average lifespan of SS104 glp-4 animals fed with live or dead E. coli OP50. Results expressed as days ± SD.
Table 3. Average lifespan of SS104 glp-4 animals fed with live or dead E. coli OP50. Results expressed as days ± SD.
Average Lifespan (Days)
SampleAlive E. coliDead E. coli
Control13.90 ± 4.4017.44 ± 2.90
Guarana 100 µg/mL16.49 ± 4.0417.84 ± 3.70
Guarana 250 µg/mL17.47 ± 3.3718.68 ± 2.86
Guarana 500 µg/mL18.42 ± 3.1919.47 ± 0.31
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Reigada, I.; Kapp, K.; Maynard, C.; Weinkove, D.; Valero, M.S.; Langa, E.; Hanski, L.; Gómez-Rincón, C. Alterations in Bacterial Metabolism Contribute to the Lifespan Extension Exerted by Guarana in Caenorhabditis elegans. Nutrients 2022, 14, 1986. https://doi.org/10.3390/nu14091986

AMA Style

Reigada I, Kapp K, Maynard C, Weinkove D, Valero MS, Langa E, Hanski L, Gómez-Rincón C. Alterations in Bacterial Metabolism Contribute to the Lifespan Extension Exerted by Guarana in Caenorhabditis elegans. Nutrients. 2022; 14(9):1986. https://doi.org/10.3390/nu14091986

Chicago/Turabian Style

Reigada, Inés, Karmen Kapp, Claire Maynard, David Weinkove, Marta Sofía Valero, Elisa Langa, Leena Hanski, and Carlota Gómez-Rincón. 2022. "Alterations in Bacterial Metabolism Contribute to the Lifespan Extension Exerted by Guarana in Caenorhabditis elegans" Nutrients 14, no. 9: 1986. https://doi.org/10.3390/nu14091986

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop